dc.contributor.editor | Nabavi, Seyed Mohammad | es |
dc.creator | Shirooie, Samira | es |
dc.creator | Nabavi, Seyed Fazel | es |
dc.creator | Dehpour, Ahmad R. | es |
dc.creator | Belwal, Tarun | es |
dc.creator | Habtemariam, Solomon | es |
dc.creator | Argüelles Castilla, Sandro | es |
dc.creator | Nabavi, Seyed Mohammad | es |
dc.date.accessioned | 2020-05-08T09:26:08Z | |
dc.date.available | 2020-05-08T09:26:08Z | |
dc.date.issued | 2018-09 | |
dc.identifier.citation | Shirooie, S., Nabavi, S.F., Dehpour, A.R., Belwal, T., Habtemariam, S., Argüelles Castilla, S. y Nabavi, S.M. (2018). Targeting mTORs by omega-3 fatty acids: a possible novel therapeutic strategy for neurodegeneration?. Pharmacological Research, 135, 37-48. | |
dc.identifier.issn | 1043-6618 | es |
dc.identifier.uri | https://hdl.handle.net/11441/96286 | |
dc.description.abstract | Neurodegenerative diseases (NDs) such as Parkinson's (PD), Alzheimer's (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) cause significant world-wide morbidity and mortality. To date, there is no drug of cure for these, mostly age-related diseases, although approaches in delaying the pathology and/or giving patients some symptomatic relief have been adopted for the last few decades. Various studies in recent years have shown the beneficial effects of omega-3 poly unsaturated fatty acids (PUFAs) through diverse mechanisms including anti-inflammatory effects. This review now assesses the potential of this class of compounds in NDs therapy through specific action against the mammalian target of rapamycin (mTOR) signaling pathway. The role of mTOR in neurodegenerative diseases and targeted therapies by PUFAs are discussed. | es |
dc.format | application/pdf | es |
dc.format.extent | 11 p. | es |
dc.language.iso | eng | es |
dc.publisher | Elsevier | es |
dc.relation.ispartof | Pharmacological Research, 135, 37-48. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Neurodegenerative diseases | es |
dc.subject | mTOR | es |
dc.subject | omega-3 | es |
dc.subject | Docosahexaenoic acid | es |
dc.subject | Eicosapentaenoic acid | es |
dc.title | Targeting mTORs by omega-3 fatty acids: a possible novel therapeutic strategy for neurodegeneration? | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/acceptedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Fisiología | es |
dc.relation.publisherversion | https://doi.org/10.1016/j.phrs.2018.07.004 | es |
dc.identifier.doi | 10.1016/j.phrs.2018.07.004 | es |
dc.journaltitle | Pharmacological Research | es |
dc.publication.volumen | 135 | es |
dc.publication.initialPage | 37 | es |
dc.publication.endPage | 48 | es |
dc.identifier.sisius | 21599743 | es |